12.14: Chapter Summary

Transfection introduces nucleic acid into cells. Plasmid DNA, mRNA, and siRNA have different roles. Plasmid-based protein production needs transcription and translation; introduced protein-coding mRNA bypasses the transcription step. siRNA helps reduce a target message rather than deleting the gene.

Delivery depends on the cells, reagent, cargo, and conditions. Match controls to the experiment and calculate amounts from final volume. Reporter positivity, viable cell recovery, target RNA, and target protein measure different outcomes. A high positive fraction can still occur when many cells have been lost.

Interpret hTERT knockdown and NAMPT expression using the right sampling times and assays. An assay may detect introduced and cell-made RNA together. RNA and protein can change at different rates. Keep treatment records linked to later measurements and avoid claiming a mechanism from one signal.

Key Terms

Transfection	Gene expression	transcription	translation
Plasmid	promoter	mRNA	siRNA
Transient expression	stable expression	Knockdown	knockout
RISC	guide strand	Off-target effect	rescue experiment
Lipofection	electroporation	endosomal escape	RNase
Empty-vector control	non-targeting siRNA	Reporter	transfection efficiency
Normalization	hTERT	NAMPT	NAD⁺

Review Questions

1. Trace the steps from plasmid DNA delivery to protein production. Which steps are bypassed by introducing protein-coding mRNA?

2. Explain how siRNA differs from mRNA and why knockdown differs from knockout.

3. Why does a fluorescently labeled RNA inside a cell outline not necessarily demonstrate functional delivery?

4. Explain why a transient reporter signal does not establish a stable cell line or genomic integration.

5. Design a control set for an hTERT siRNA experiment. State which question each control helps answer.

6. Design a control set for a NAMPT mRNA experiment. Explain why reagent-only and control-mRNA conditions are different.

7. Calculate the volume of a 10 µM siRNA stock needed for 25 nM in a final 1.0 mL well. How would the concentration change if the same amount were placed in 2.0 mL?

8. A plan needs 0.8 µg mRNA per well for six wells plus a 10% preparation allowance. The stock is 0.16 µg/µL. Calculate the total amount and stock volume, and explain how the allowance is used.

9. A condition yields 80,000 viable cells with 50% reporter positivity. Another yields 40,000 with 90% positivity. Calculate viable reporter-positive cells and explain why the higher percentage is not the whole result.

10. Normalized target expression is 0.45 relative to a control value of 1.00. Calculate the relative knockdown and state what the calculation does not establish.

11. Why can target protein remain after its mRNA falls? How should that possibility affect sampling times?

12. Two siRNAs reduce target RNA, but only one changes the functional endpoint. Identify three explanations to investigate.

13. A NAMPT RNA assay measures a sequence shared by introduced and endogenous RNA. What can and cannot be concluded from a higher signal after delivery?

14. Explain how cell loss and a changing reference measurement can each distort a normalized result.

15. Identify the records needed to reconstruct a transfection treatment and connect it to a later RNA or protein result.

Apply Your Understanding

An hTERT siRNA treatment lowers target RNA but also reduces viable cell number. Identify the comparisons needed to distinguish a target-related effect from delivery-reagent stress.

Calculate the volume of a 10 µM siRNA stock required for 25 nM in a final 1.0 mL well. State why the final volume must include all additions.

Condition A gives 80,000 viable cells with 50% reporter positivity. Condition B gives 40,000 viable cells with 90% positivity. Calculate the positive viable yield in each and compare them.

NAMPT RNA increases but detected protein does not at the same time. Propose two explanations and a follow-up measurement that could help distinguish them.